Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2a,Condition 2b,Condition 2c
2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",glomerular filtration trait,,RS:0000592,MW,male,0 days,6,,CMO:0000490,glomerular filtration rate,,,,0.05,ml/min,0.01,0.0245,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days),100883,right nephrectomy (for 112 days),,,
2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",glomerular filtration trait,,RS:0000592,MW,male,0 days,10,,CMO:0000490,glomerular filtration rate,,,,0.32,ml/min,0.01,0.0316,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then reserpine (5 mg/l) (for 56 days) and hydralazine (80 mg/l) (for 56 days) and controlled hydralazine content drinking water (25 mg/l) (for 56 days),100884,right nephrectomy (for 112 days),reserpine (5 mg/l) (for 56 days),hydralazine (80 mg/l) (for 56 days),controlled hydralazine content drinking water (25 mg/l) (for 56 days)
2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",glomerular filtration trait,,RS:0000592,MW,male,0 days,10,,CMO:0000490,glomerular filtration rate,,,,0.67,ml/min,0.1,0.3162,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then captopril (30 mg/kg/d) (for 56 days),100885,right nephrectomy (for 112 days),captopril (30 mg/kg/d) (for 56 days),,
2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",glomerular filtration trait,,RS:0000592,MW,male,0 days,9,,CMO:0000490,glomerular filtration rate,,,,0.38,ml/min,0.1,0.3,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then enalapril (20 mg/kg/d) (for 56 days),100886,right nephrectomy (for 112 days),enalapril (20 mg/kg/d) (for 56 days),,
2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",glomerular filtration trait,,RS:0000592,MW,male,0 days,10,,CMO:0000490,glomerular filtration rate,,,,0.36,ml/min,0.05,0.1581,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then lisinopril (10 mg/kg/d) (for 56 days),100887,right nephrectomy (for 112 days),lisinopril (10 mg/kg/d) (for 56 days),,
2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",glomerular filtration trait,,RS:0000592,MW,male,0 days,7,,CMO:0000490,glomerular filtration rate,,,,0.36,ml/min,0.06,0.1587,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then angiotensin II receptor antagonist (20 mg/l) (for 56 days),100888,right nephrectomy (for 112 days),angiotensin II receptor antagonist (20 mg/l) (for 56 days),,
2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",glomerular filtration trait,,RS:0000592,MW,male,0 days,5,,CMO:0000490,glomerular filtration rate,,,,0.42,ml/min,0.06,0.1342,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then angiotensin II receptor antagonist (80 mg/l) (for 56 days),100889,right nephrectomy (for 112 days),angiotensin II receptor antagonist (80 mg/l) (for 56 days),,